Generics Maker Teva Offers $82 per Share for Mylan
April 21, 2015 at 09:01 AM EDT
The generic drugmaker said Tuesday morning it made an offer to buy rival Mylan for $82 per share in a cash-and-stock deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.